XML 50 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Goodwill and Other Purchased Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes to goodwill by segment
Changes to goodwill by segment were as follows (in millions):
 20242023
Life
Science
Clinical
Diagnostics
TotalLife
Science
Clinical
Diagnostics
Total
Balances as of January 1:      
Goodwill$333.3 $415.5 $748.8 $333.3 $408.4 $741.7 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net291.5 122.1 413.6 291.5 115.0 406.5 
Acquisitions
— — — — 0.4 0.4 
Foreign currency adjustments— (3.1)(3.1)— 6.7 6.7 
Period change, net— (3.1)(3.1)— 7.1 7.1 
Balances as of December 31:      
Goodwill333.3 412.4 745.7 333.3 415.5 748.8 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net$291.5 $119.0 $410.5 $291.5 $122.1 $413.6 
Schedule of Finite-Lived Intangible Assets by Major-Class
Information regarding our identifiable purchased intangible assets with finite and indefinite lives is as follows (in millions):
December 31, 2024
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists4.6$102.9 $(95.6)$7.3 
Know how0.8163.4 (160.0)3.4 
Developed product technology11.5215.5 (140.4)75.1 
Licenses4.058.7 (45.6)13.1 
Tradenames4.65.9 (4.8)1.1 
Covenants not to compete1.36.4 (5.5)0.9 
     Total finite-lived intangible assets552.8 (451.9)100.9 
In-process research and development192.7 — 192.7 
     Total purchased intangible assets$745.5 $(451.9)$293.6 




 December 31, 2023
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists5.2$108.7 $(98.9)$9.8 
Know how1.8168.9 (161.1)7.8 
Developed product technology12.0217.8 (132.9)84.9 
Licenses4.959.2 (42.4)16.8 
Tradenames5.66.1 (4.7)1.4 
Covenants not to compete2.36.4 (4.8)1.6 
Total finite-lived intangible assets 567.1 (444.8)122.3 
In-process research and development198.2 — 198.2 
Total purchased intangible assets$765.3 $(444.8)$320.5